Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants

Background:The safety profiles of standard therapy versus everolimus with reduced-exposure calcineurin inhibitor (CNI) therapy using contemporary protocols in de novo kidney transplant recipients have not been compared in detail.Methods:TRANSFORM was a randomized, international trial in which de nov